INTERNATIONAL PATENT: HUIDAGENE THERAPEUTICS CO., LTD., HUIDAGENE THERAPEUTICS (SINGAPORE) PTE. LTD. FILES APPLICATION FOR "ISCB POLYPEPTIDES AND USES THEREOF"

GENEVA, July 19 -- HUIDAGENE THERAPEUTICS CO., LTD. (Room 1002, Building #7-1, No. 160 Basheng RoadPudong New Area, Shanghai 201203), HUIDAGENE THERAPEUTICS (SINGAPORE) PTE. LTD. (987 Serangoon Road328147) filed a patent application (PCT/CN2025/072127) for "ISCB POLYPEPTIDES AND USES THEREOF" on Jan 13, 2025. With publication no. WO/2025/149083, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Hainan (c/o HuidaGene Therapeutics Co., Ltd., Room 1002, Building #7-1, No. 160 Basheng RoadPudong New Area, Shanghai 201203...